Medical Advisor (MA)/Senior Medical Science Liaison (Senior MSL)

Medical Advisor (MA)/Senior Medical Science Liaison (Senior MSL)

About AstraZeneca and AstraZeneca Vietnam

AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.

AstraZeneca Vietnam

As a Foreign Invested Enterprise with over 750 members, AstraZeneca is investing into Vietnam 360 million USD from 2020 to 2030 with a focus on reducing the burdens of non-communicable diseases, developing local talent, and uplifting the domestic biopharmaceutical R&D and manufacturing capabilities.

Over the last three decades accompanying Vietnam’s sustainable development, AstraZeneca has run several impactful programmes in collaboration with the Government, Ministry of Health and healthcare partners to promote disease awareness, prevention and early detection. In recent years, AstraZeneca Vietnam has received several certificates of merit from the Prime Minister and Minister of Health, for excellent contributions to Vietnam’s vaccine diplomacy, fight against COVID-19 and advancement of cancer treatment and disease awareness. The company has also been recognized among Vietnam’s Top 100 Best Places to Work (2018 – 2026) with various other industry awards from BritCham, EuroCham, and government agencies.

What you’ll do

Job Description / Capsule

An external and internal facing role that provides medical and clinical expertise in priority therapeutic areas and builds AZ scientific leadership. The role focuses on the development of professional relationships with OLs, building deep scientific understanding of AstraZeneca compounds by engaging OLs in ESRs, scientific exchange meetings and advisory board meetings. In addition the Medical Advisor will input into Brand Strategy and LCM and take the lead in the design and implementation of medical activities aligned with Brand Strategy. Further internal accountabilities include the delivery of medical education and clinical support to medical professionals, training sales teams and involvement in development of brand strategy.

May take responsibility as Nominated Signatory reviewer for activities and promotional materials. May take responsibility for mentorship of MSL/s in the country. May lead Medical Information and Pharmacovigilance within a particular market.

Objective

Critical actions

Measures (QQA)

External Medical & Scientific engagement

Build, enhance and maintain the engagement with scientific leaders (OLs).

50% of time in field engaging HCPs and key external stakeholders engagement

• •Proactively identify HCPs with high levels of scientific expertise in local treatment practice to collaborate on specific medico marketing activities
• •Development and implementation of OL engagement plan in collaboration with line manager and TA lead..

Develop database of Key opinion leaders and also provide recommendations for advisory board participation, potential speakers and train speakers as appropriate.

• •Develop own scientific knowledge and share emerging data with HCPs, discussing all aspects of the data in a scientific, objective and balanced way. Disseminate results of studies completed to medical community by translating their clinical values and incorporating into business strategies.
• •Respond to unsolicited requests for information about unapproved AZ products or unapproved uses of approved products, presenting such information in an objective, scientifically balanced, substantiated manner.

Quantity

• •50% of available time spent meeting OLs. (Available time = total days minus, holidays, weekends, sickness)
• •Coverage of OLs versus plan
• •No of Advisory Board Meetings versus plan
• •No of P2Ps/round table discussions versus plan
• •No of CMEs versus plan
• •Improvement in advocacy score as reviewed by line manager1:1

Quality

• •Meeting skills and presentation skills based on in field coaching and annual role play assessment – use standard assessment form
• •Positive customer feedback post events

Develop or initiate scientific programs to explore unmet medical needs in priority disease area(s)

• •Discuss potential involvement in ESR and RWEs. Interact in the field with KOLs for clinical trials, ESRs
• •Able to conduct basic discussions on clinical trials in terms of study design and feasibility

Quantity

No of ESRs communicated

Quality

• •Customer feedback
• •In field observation by line manager and coaching form

Medical & Scientific Support for internal stakeholders

To establish AstraZeneca as a scientific leader through proactive, updated and effective Medical input

Provide the AZ internal stakeholders with an understanding of the local medical community, clinical practice, trends and real or perceived gaps in current scientific knowledge and medical treatment, competitive intelligence

Provide medical input for the development of company’s Brand plans

Develop and implement the local medical plan to address unmet medical needs in priority disease areas and ensure alignment with the brand plan.

Develop and implement pre-launch medical plan/activities for new products at least 2 years prior to the planned launch in the country to address key clinical and scientific challenges

Provide medical leadership on faculty and content development for medical programmes including national congresses, advisory boards, scientific exchange meetings, publications, CMEs to meet identified needs

Provide medical input to global protocols, study feasibility and local customer’s research initiatives.

Quantity

% of trainings conducted versus plan

Quality

Feedback from participants

• •Feedback from business partners on quality of contribution to Medical and Brand plans – collected by line manager
• •Feedback on congress report/highlights shared with cross-functional team as planned – completed feedback templates

Provide medical input into the Life Cycle Management of priority brands and TAs to meet unmet medical needs

• •Participate as key member of brand team as strategic partner towards LCM actions
• •Develop NIS or registry studies to address unmet med ical needs
• •Initiate discussions with customers to develop studies that will fulfil global and local business strategies.

• •ESR Proposals- Number
• •For NIS number of sites, KOLs, investigators involved in studies versus plan
• •Timely publications of studies completed

Governance and ensuring overall adherence to processes and regulation [include but not limit to patient safety, clinical trials, promotional activities, etc…]

• •Provide medical input to the creation, development and agreement of promotional material and ensure all material is in line with internal SOPs and meets IFPMA code
• •Support Clinical team to select appropriate investigators and sites optimising quality, delivery and commercial benefit
• •Ensures compliance with AZ code of conduct, Corporate Governance, Audits requirement, guidelines, codes, policies and procedures
• •Ensures that company confidentiality is maintained (i.e. intellectual property, product, strategic and salary information)
• •Discloses potential breach of codes or conducts

• •Display behaviours consistent with the AZ vision and values (those with line report, their team members demonstrates the same)
• •Feedback from others; climate survey
• •No valid complaints from competitors against marketing practice
• •No breach of confidentiality. All disclosures are investigated and resolved
• •No critical finding in relevant internal or regulatory authority audits

Development

Continuously demonstrate development of scientific expertise in diseas